Epilepsy, a chronic neurological disorder, is characterized by recurrent seizures affecting approximately 50 million people globally. Despite the progress in therapeutic strategies, about one-third of patients continue to experience uncontrolled seizures. This article aims to shed light on the recent advancements in epilepsy management, offering a comprehensive update for healthcare professionals.
Newer AEDs offer improved safety profiles, fewer drug interactions, and better tolerability. Drugs such as Brivaracetam, Perampanel, and Lacosamide have shown promising results in controlling both focal and generalized seizures. These drugs work by modulating synaptic transmission, thereby reducing the frequency and severity of seizures.
Neuromodulation therapies such as Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), and Responsive Neurostimulation (RNS) have emerged as effective treatment options for drug-resistant epilepsy. These therapies work by altering neuronal activity, thereby reducing seizure frequency. RNS, in particular, has shown potential in detecting abnormal electrical activity and delivering corrective stimulation.
Genetic testing has greatly improved our understanding of epilepsy's etiology, leading to the development of precision medicine. Identifying specific genetic mutations allows for targeted therapy, improving treatment outcomes. For instance, Stiripentol has been approved for Dravet syndrome, a severe form of epilepsy caused by SCN1A mutations.
The COVID-19 pandemic has accelerated the adoption of telemedicine in epilepsy care. Telemedicine allows for remote patient monitoring, improving treatment adherence and seizure control. Additionally, digital tools such as seizure detection apps and wearable devices provide real-time data, facilitating personalized care.
In conclusion, the field of epilepsy management has seen significant advancements. The introduction of new AEDs, neuromodulation therapies, precision medicine, and digital tools have improved patient outcomes. As healthcare professionals, staying updated with these advancements is crucial to provide optimal care for patients with epilepsy.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation